Market Research Logo

Global bone marrow transplant market 2017-2021

Global bone marrow transplant market 2017-2021

About Bone Marrow Transplant

Bone marrow transplant is the medical procedure that is performed to replace the damaged or destroyed bone marrow due to infections, disease, or adverse effect of treatment. A normal bone marrow transplant includes transplantation of blood stem cell that travels to the bone marrow to produce new blood cell and thus improves growth of new marrow. When the bone marrow is damaged due to disease, allogeneic transplant is used whereas autologous transplant is used when bone marrow is intact at the start of disease but it gets damaged due to therapy.

Technavio’s analysts forecast the global bone marrow transplant market to grow at a CAGR of 5.39% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global bone marrow transplant market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Bone Marrow Transplant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AllCells
  • Lonza
  • Merck
  • Sanofi
Other prominent vendors
  • Athersys
  • Beike Biotechnology
  • BioTime
  • bluebird bio
  • Caladrius
  • Cellular Biomedicine Group
  • Cellular Dynamics International (a subsidiary of Fujifilm)
  • Cesca Therapeutics
  • CHA Biotech
  • Chugai Pharmaceutical
  • CORESTEM
  • Gamida Cell
  • Global Stem Cells Group
  • Hemostemix
  • Histocell
  • Mesoblast
  • TiGenix
  • Translational Biosciences (a subsidiary of Medistem Panama)
Market driver
  • Technological advancement
  • For a full, detailed list, view our report
Market challenge
  • Scarcity of donors and its genetical acceptance
  • For a full, detailed list, view our report
Market trend
  • Growing number of registry
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Bone Marrow Transplant Market 2017-2021

Technavio recognizes the following companies as the key players in the global bone marrow transplant market: AllCells, Lonza, Merck, and Sanofi.

Other Prominent Vendors in the market are: Athersys, Beike Biotechnology, BioTime, bluebird bio, Caladrius, Cellular Biomedicine Group, Cellular Dynamics International (a subsidiary of Fujifilm), Cesca Therapeutics, CHA Biotech, Chugai Pharmaceutical, CORESTEM, Gamida Cell, Global Stem Cells Group, Hemostemix, Histocell, Mesoblast, TiGenix, and Translational Biosciences (a subsidiary of Medistem Panama).

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is growing number of registry. The number of the donor registry is increasing in recent times globally. Thus, the challenge of scarcity of donor can be fulfilled for future. The European Group for Blood and Marrow Transplant has started an initiative named Bone Marrow Donors Worldwide (BMDW) in which around 52 major countries across the globe have participated.”

According to the report, one driver in the market is technological advancement. The first transplant of bone marrow was carried out in 1956, and since then there have been tremendous improvements as far as technology is concerned. The advancement in technology has led to the more safer procedure and higher success rates of bone marrow transplant. This has improved the acceptance of this procedure, and the number of transplants has improved in recent years.

Further, the report states that one challenge in the market is scarcity of donors and its genetical acceptance. The supply and demand for bone marrow transplant are an imbalance, and it is one of the major challenges for this market. The demand of bone marrow transplant is increasing due to growing prevalence of the various chronic diseases such as cancer and blood-related disorders such as anemia. However, on the other side, the supply of bone marrow is poor due to lesser donors compared with the over-increasing demand.

Companies Mentioned

AllCells, Lonza, Merck, Sanofi, Athersys, Beike Biotechnology, BioTime, bluebird bio, Caladrius, Cellular Biomedicine Group, Cellular Dynamics International, Cesca Therapeutics, CHA Biotech, Chugai Pharmaceutical, CORESTEM, Gamida Cell, Global Stem Cells Group, Hemostemix, Histocell, Mesoblast, TiGenix, and Translational Biosciences

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Table Various blood components formed by bone marrow
    • Table Five phases of transplant process
    • Table Major reasons for bone marrow damage
    • Table Complications associated with bone marrow transplant
  • Market landscape
    • Market overview
      • Table Global bone marrow transplant market snapshot
      • Table Global bone marrow transplant market 2016-2021 ($ millions)
      • Table Opportunity analysis in global bone marrow transplant market
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by transplant type
    • Table Market segmentation by application 2016
    • Autologous bone marrow transplant
      • Table Global autologous bone marrow transplant market 2016-2021 ($ millions)
    • Allogeneic bone marrow transplant
      • Table Global allogeneic bone marrow transplantation market 2016-2021 ($ millions)
  • Market segmentation by indication
    • Table Bone marrow transplant in various disease conditions 2016
    • Multiple myeloma
      • Table Average share of transplant types in multiple myeloma treatment 2010-2014
    • Acute leukemia
      • Table Average share of transplant types in acute leukemia treatment 2010-2014
    • Hodgkin lymphoma
      • Table Average share of transplant types in Hodgkin lymphoma treatment 2010-2014
    • Non-Hodgkin lymphoma
      • Table Average share of transplant types in non-Hodgkin lymphoma treatment 2010-2014
    • Solid tumors
      • Table Average share of transplant types in solid tumors treatment 2010-2014
    • Others
      • Table Bone marrow transplantation in various other diseases
  • Geographical segmentation
    • Table Segmentation of global bone marrow transplant market by geography 2016 and 2021
    • Table Segmentation of global bone marrow transplant market revenue by geography 2016-2021 ($ millions)
    • Bone marrow transplant market in EMEA
      • Table Market scenario in EMEA
      • Table Bone marrow transplant market in EMEA 2016-2021 ($ millions)
    • Bone marrow transplant market in Americas
      • Table Market scenario in Americas
      • Table Bone marrow transplant market in Americas 2016-2021 ($ millions)
    • Bone marrow transplant market in APAC
      • Table Market Scenario in APAC
      • Table Bone marrow transplant market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Various major types of cancers managed by bone marrow transplant
      • Table NIH: YoY and growth rate of spending toward stem cell research ($ billions)
    • Market challenges
      • Table Various phases of bone marrow transplant treatment
      • Table The supply gap of donors for fulfilling demand of bone marrow
      • Table Three ethical requirements for bone marrow transplant
      • Table Various consideration for ethically bound transplant process
  • Market trends
    • Newer application of bone marrow transplant
      • Table Newer applications of bone marrow transplant
    • Growing number of registry
      • Table Number of registry across 52 major countries
    • Online services
      • Table Number of online matches under various programs
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global bone marrow transplant market 2016
      • Table Market penetration of various vendors 2016
      • Table Strategic success factors of companies in global bone marrow transplant market
  • Key vendor analysis
    • AllCells
      • Table AllCells: Key highlights
      • Table AllCells: Strength assessment
      • Table AllCells: Strategy assessment
      • Table AllCells: Opportunity assessment
    • Lonza
      • Table Lonza: Key highlights
      • Table Lonza: Strength assessment
      • Table Lonza: Strategy assessment
      • Table Lonza: Opportunity assessment
    • Merck
      • Table Merck: Key highlights
      • Table Merck: Strength assessment
      • Table Merck: Strategy assessment
      • Table Merck: Opportunity assessment
    • Sanofi
      • Table Sanofi: Key highlights
      • Table Sanofi: Strength assessment
      • Table Sanofi: Strategy assessment
      • Table Sanofi: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report